Phase II Trial of FOLFOX in Combination With Cetuximab and Concomitant Radiotherapy in the Treatment of Esophageal Cancer Stage III

Trial Profile

Phase II Trial of FOLFOX in Combination With Cetuximab and Concomitant Radiotherapy in the Treatment of Esophageal Cancer Stage III

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Jul 2012

At a glance

  • Drugs Cetuximab (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
  • Indications Oesophageal cancer
  • Focus Therapeutic Use
  • Acronyms ERAFOX
  • Most Recent Events

    • 04 Jul 2012 Last checked against European Clinical Trials Database record.
    • 30 Mar 2011 Actual end date (Feb 2011) added as reported by ClinicalTrials.gov.
    • 30 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top